Longitudinal changes in laboratory parameters and QTc during isavuconazole therapy in Japanese patients with hematologic malignancies
PLoS One. 2026 Jul 29;21(7):e0354816. doi: 10.1371/journal.pone.0354816. eCollection 2026.ABSTRACTBACKGROUND: Isavuconazole (ISCZ) is an azole antifungal with a low risk of QTc prolongation and no requirement for renal dose adjustment. However, real-world data in Asian patients remain limited.METHOD
